EDGAR Filing Documents for 0001104659-14-059391

Form 8-K - Current report:

SEC Accession No. 0001104659-14-059391

Filing Date

2014-08-11

Accepted

2014-08-11 16:15:22

Documents

Period of Report

2014-08-05

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a14-18804_18k.htm	8-K	35059
2	EX-10.1	a14-18804_1ex10d1.htm	EX-10.1	58463
3	EX-99.1	a14-18804_1ex99d1.htm	EX-99.1	82504
4	EX-99.2	a14-18804_1ex99d2.htm	EX-99.2	8170
5	GRAPHIC	g188041ksi001.jpg	GRAPHIC	3130
	Complete submission text file	0001104659-14-059391.txt		190085

Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301

Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800

Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)